{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:57:30Z","timestamp":1781701050228,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.ygyno.2008.12.027","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T04:11:43Z","timestamp":1233461503000},"page":"57-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III\/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206"],"prefix":"10.1016","volume":"113","clinical-trial-number":[{"clinical-trial-number":"nct00075712","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00112086","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Takashi","family":"Onda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hatae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Iwasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Kamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.12.027_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/gyno.2000.5926","article-title":"A critique of surgical cytoreduction in advanced ovarian cancer","volume":"78","author":"Covens","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-2388(200007\/08)19:1<42::AID-SSU7>3.0.CO;2-M","article-title":"Cytoreductive surgery for advanced stages of ovarian cancer","volume":"19","author":"Dauplat","year":"2000","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib3","first-page":"326","article-title":"The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery","volume":"25","author":"Boente","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0090-8258(91)90335-3","article-title":"Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer","volume":"42","author":"Jacob","year":"1991","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib5","first-page":"393","article-title":"Neoadjuvant chemotherapy in advanced ovarian cancer","volume":"17","author":"Onnis","year":"1996","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1998.5236","article-title":"Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival","volume":"72","author":"Schwartz","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.1998.5213","article-title":"Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients","volume":"71","author":"Vergote","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1098-2388(200007\/08)19:1<49::AID-SSU8>3.0.CO;2-Z","article-title":"Interval debulking surgery: an alternative for primary surgical debulking?","volume":"19","author":"Vergote","year":"2000","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jjco\/hyh007","article-title":"Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III\/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206","volume":"34","author":"Onda","year":"2004","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib10","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","article-title":"Carboplatin dosage: prospective evaluation of a simple formula based on renal function","volume":"7","author":"Calvert","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.ygyno.2008.12.027_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2008.12.027_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/ijgc-00009577-200111000-00007","article-title":"Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma","volume":"11","author":"Kayik\u00e7io\u011flu","year":"2001","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2008.12.027_bib14","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/1097-0142(20011115)92:10<2585::AID-CNCR1611>3.0.CO;2-#","article-title":"Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma","volume":"92","author":"Kuhn","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.12.027_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.12.027_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/92.9.699","article-title":"Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results","volume":"92","author":"Piccart","year":"2000","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2008.12.027_bib17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1200\/JCO.1992.10.5.718","article-title":"Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group","volume":"10","author":"Swenerton","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.1992.10.5.706","article-title":"Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer","volume":"10","author":"Alberts","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0090-8258(87)90210-1","article-title":"A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinoma","volume":"28","author":"Bertelsen","year":"1987","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib20","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"du Bois","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2008.12.027_bib21","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.027_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.12.027_bib23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/jjco\/hym145","article-title":"Phase III trial of upfront debulking surgery vs. neoadjuvant chemotherapy for stage III\/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602","volume":"38","author":"Onda","year":"2008","journal-title":"Jpn. J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808011189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808011189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:28:46Z","timestamp":1758770926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808011189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0090825808011189"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.12.027","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III\/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}